Patent · US Active

Tricyclic PI3K inhibitor compounds and methods of use

US10065970B2 · kind B2 · utility

1Cited by
5References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2016
Grant dateSep 4, 2018
Priority date—
Expiry dateSep 7, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are tricyclic compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.